[Congressional Record Volume 170, Number 148 (Monday, September 23, 2024)]
[House]
[Pages H5576-H5577]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
NAPA REAUTHORIZATION ACT
Mr. BUCSHON. Mr. Speaker, I move to suspend the rules and pass the
bill (S. 133) to extend the National Alzheimer's Project.
The Clerk read the title of the bill.
The text of the bill is as follows:
S. 133
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``NAPA Reauthorization Act''.
SEC. 2. EXTENSION OF PROJECT.
Section 2 of the National Alzheimer's Project Act (42
U.S.C. 11225) is amended--
(1) in subsection (c)--
(A) in paragraph (2), by striking ``and coordination of''
and inserting ``on, and coordination of,'';
(B) in paragraph (4)--
(i) by redesignating subparagraphs (A) and (B) as
subparagraphs (B) and (C), respectively; and
(ii) by inserting before subparagraph (B), as so
redesignated, the following:
``(A) promotion of healthy aging and reduction and
mitigation of risk factors for Alzheimer's;'';
(C) in paragraph (5)--
(i) by inserting ``and other underserved populations,
including individuals with developmental disabilities such as
Down syndrome,'' after ``populations''; and
(ii) by striking ``; and'' and inserting a semicolon;
(D) by redesignating paragraph (6) as paragraph (7); and
(E) by inserting after paragraph (5) the following:
``(6) provide information on, and promote the adoption of,
healthy behaviors that may reduce the risk of cognitive
decline and promote and protect cognitive health; and'';
(2) in subsection (d)(2)--
(A) by inserting ``, across public and private sectors,''
after ``Nation's progress''; and
(B) by inserting ``, including consideration of public-
private collaborations, as appropriate'' before the period;
(3) in subsection (e)--
(A) in paragraph (2)--
(i) in subparagraph (A), by adding at the end the
following:
[[Page H5577]]
``(xi) A designee of the Department of Justice.
``(xii) A designee of the Federal Emergency Management
Agency.
``(xiii) A designee of the Social Security Administration.
``(xiv) 2 or more other designees, as determined by the
Secretary of Health and Human Services, at least one of whom
has expertise in risk factors associated with the development
or the progression of Alzheimer's.''; and
(ii) in subparagraph (B)--
(I) in the matter preceding clause (i), by striking ``12''
and inserting ``15'';
(II) in clause (v)--
(aa) by striking ``2 researchers'' and inserting ``3
researchers''; and
(bb) by striking ``; and'' and inserting ``, including at
least one researcher with demonstrated experience in
recruitment and retention of underrepresented groups into
research or clinical trials related to dementia;'';
(III) in clause (vi), by striking the period and inserting
a semicolon; and
(IV) by adding at the end the following:
``(vii) 1 individual with a diagnosis of Alzheimer's
disease; and
``(viii) 1 representative from a historically underserved
population whose lifetime risk for developing Alzheimer's is
markedly higher than that of other populations.'';
(B) in paragraph (5)--
(i) in subparagraph (A)--
(I) by striking ``an initial evaluation'' and inserting
``annual evaluations''; and
(II) by striking ``research, clinical'' and inserting
``research, risk reduction, public health, clinical'';
(ii) in subparagraph (B), by striking ``initial'';
(iii) in subparagraph (C)--
(I) in the matter preceding clause (i), by striking
``initial''; and
(II) in clause (ii), by inserting ``and reduce
disparities'' before the semicolon; and
(iv) in subparagraph (D), by striking ``annually
thereafter, an evaluation'' and inserting ``annual
evaluations''; and
(C) in paragraph (6), by striking ``2025'' and inserting
``2035'';
(4) in subsection (g)--
(A) in paragraph (1)--
(i) by adding ``and'' after the semicolon;
(ii) by striking ``that includes an evaluation'' and
inserting ``that includes--
``(A) an evaluation;''; and
(iii) by adding at the end the following:
``(B) a summary of the Secretary's process for identifying
and updating what conditions constitute Alzheimer's
disease;''; and
(B) in paragraph (3)(A)(ii), by inserting ``and reduce
disparities'' before the semicolon; and
(5) in subsection (h), by striking ``2025'' and inserting
``2035''.
The SPEAKER pro tempore. Pursuant to the rule, the gentleman from
Indiana (Mr. Bucshon) and the gentleman from New Jersey (Mr. Pallone)
each will control 20 minutes.
The Chair recognizes the gentleman from Indiana.
General Leave
Mr. BUCSHON. Mr. Speaker, I ask unanimous consent that all Members
may have 5 legislative days in which to revise and extend their remarks
and include extraneous material in the Record on the bill.
The SPEAKER pro tempore. Is there objection to the request of the
gentleman from Indiana?
There was no objection.
Mr. BUCSHON. Mr. Speaker, I yield myself such time as I may consume.
Mr. Speaker, I rise in support of S. 133, the NAPA Reauthorization
Act led by Senators Collins and Warren.
The House companion bill, H.R. 619, is led by Representatives Tonko
and Smith of New Jersey.
In the United States, one in nine people aged 65 and older currently
suffer from Alzheimer's disease. Unfortunately, this number continues
to grow with some estimates projecting the overall number to rise to
12.7 million Americans by 2050.
Congress established the National Alzheimer's Project in 2011 with a
goal of building upon, raising awareness of, and helping to coordinate
current Federal efforts to combat Alzheimer's disease and related
dementia through earlier diagnosis, prevention, and improved
treatments.
This bill would support and improve the National Alzheimer's Project,
including expanding membership of the advisory council to include those
individuals battling this disease and those at high risk for developing
Alzheimer's.
Mr. Speaker, I encourage my colleagues to support this bill, and I
reserve the balance of my time.
Mr. PALLONE. Mr. Speaker, I yield myself such time as I may consume.
Mr. Speaker, I rise in support of S. 133, the NAPA Reauthorization
Act, which would reauthorize the National Alzheimer's Project Act
through 2035.
In 2011, our Nation made addressing Alzheimer's disease a priority
when we passed the National Alzheimer's Project Act. This law called
for a national plan to accelerate research and improve care and
services to those living with Alzheimer's. Since the establishment of
the national plan, we have made enormous strides in strategy
implementation to address Alzheimer's disease and other dementia. The
national plan has also allowed us to make progress in Alzheimer's
research, care and services, and public awareness about the disease.
S. 133 will build on the progress we have made through the national
plan by reauthorizing the law through fiscal year 2035. The bill will
also allow the national plan to address healthy aging and risk
reduction issues related to Alzheimer's disease.
This reauthorization will build on the progress brought forward by
NAPA and allow the Department of Health and Human Services to continue
long-term planning for a strategic approach to addressing Alzheimer's
and other dementia.
This bill is the Senate counterpart of legislation led by
Representative Tonko, who shepherded this bipartisan reauthorization
through the Energy and Commerce Committee this past spring. Since the
beginning of his time in Congress, Representative Tonko has led the
push to address Alzheimer's and related dementia, and I thank him for
his continued leadership.
I also thank my colleague from New Jersey, Representative Smith, who
is the Republican sponsor.
I encourage my colleagues to vote ``yes'' on S. 133 so we can
continue our commitment to combat Alzheimer's disease.
Mr. Speaker, I reserve the balance of my time.
Mr. BUCSHON. Mr. Speaker, I yield 5 minutes to the gentleman from
Georgia (Mr. Carter).
Mr. CARTER of Georgia. Mr. Speaker, I thank the gentleman for
yielding.
Mr. Speaker, I am proud to join my colleagues in supporting the
National Alzheimer's Project Reauthorization Act.
This legislation reauthorizes the National Alzheimer's Project Act
through 2035, providing a roadmap for Federal efforts in responding to
Alzheimer's and dementia.
Alzheimer's is a cruel disease that steals a person's quality of
life. As a pharmacist, I have seen firsthand the impact Alzheimer's and
other forms of dementia have on patients, families, caregivers, and
society overall.
People living with Alzheimer's lose their memories, their
independence, their relationships, and ultimately their lives. Beyond
the patients, caregivers and loved ones endure emotional distress and
unthinkable financial burdens.
With nearly 7 million Americans suffering with Alzheimer's, there is
a critical need for Federal resources to prevent, treat, and ultimately
find a cure for this devastating disease.
In honor of those who have battled and continue to battle this
disease, let's continue to work together to raise awareness and pass
this bill.
Mr. PALLONE. Mr. Speaker, I urge all of us to support this bill on a
bipartisan basis. Whatever we can do to fight Alzheimer's is very
important.
Mr. Speaker, I yield back the balance of my time.
Mr. BUCSHON. Mr. Speaker, in closing, I encourage a ``yes'' vote on
this bill, and I yield back the balance of my time.
The SPEAKER pro tempore. The question is on the motion offered by the
gentleman from Indiana (Mr. Bucshon) that the House suspend the rules
and pass the bill, S. 133.
The question was taken; and (two-thirds being in the affirmative) the
rules were suspended and the bill was passed.
A motion to reconsider was laid on the table.
____________________